Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1034 | 1034 | 1082 | 1251 | 1301 | 1741 |
Fund Return | 3.4% | 3.4% | 8.21% | 7.74% | 5.41% | 5.7% |
Place in category | 349 | 349 | 265 | 220 | 178 | 102 |
% in Category | 54 | 54 | 39 | 46 | 41 | 32 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Legal General US Index Trust F Acc | 783.48K | 10.67 | 13.38 | 15.24 | ||
Legal General US Index Trust F Dist | 20.99K | 10.62 | 13.37 | 15.23 | ||
Legal General US Index Trust C Acc | 3.71B | 7.11 | 14.19 | 15.31 | ||
Legal General US Index Trust C Dist | 977.12M | 7.07 | 14.19 | 15.30 | ||
Legal General US Index Trust I Acc | 1.44B | 7.04 | 14.13 | 15.25 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Index Unit Trust Accumulation | 14.23B | 6.08 | 7.20 | 5.78 | ||
All Share Index Unit Trust Income | 14.23B | -0.70 | 7.89 | - | ||
VG UK Plus GBP Accumulation | 14.23B | -0.70 | 7.91 | - | ||
VG UK Institutional Plus GBP Income | 14.23B | -0.69 | 7.90 | - | ||
UK Equity Tracker Fund X Acc | 11.62B | 6.09 | 7.82 | 5.98 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Shell | GB00BP6MXD84 | 7.16 | 32.90 | -0.66% | |
AstraZeneca | GB0009895292 | 6.65 | 12,110.0 | -0.46% | |
HSBC | GB0005405286 | 5.01 | 697.00 | +0.07% | |
Unilever | GB00B10RZP78 | 4.13 | 50.42 | +1.10% | |
BP | GB0007980591 | 3.48 | 491.30 | +0.41% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review